Johnson and Johnson Vaccine Temporary Pause

Grace Kaczmarek '23, Staff Writer

As things begin to open up more and more as more vaccines are distributed, there was a pause on the Johnson & Johnson vaccine due to health concerns. It was reported Six people out of about 6.8 million recipients of the vaccine experienced a rare blood clotting issue after their shots. All of these cases occurred in women between the ages of 18 and 59, with a median age of 37 years. After a review of the vaccine, the FDA and CDC lifted the pause on the administration of the vaccine and it is available to anyone over the age of 18. The CDC says that the benefits of the vaccine outweigh the possible, but rare, side effects such as blood clots. The FDA and CDC will continue to monitor all vaccine progress and the safety of the vaccines as more people receive them.